Evidence map›Paper›PMID 23135609›Full record

ArticlePediatric nephrology (Berlin, Germany)2013

Mitochondrial tRNA(Phe) mutation as a cause of end-stage renal disease in childhood.

Kristin E D'Aco, Megan Manno, Colleen Clarke, Jaya Ganesh, Kevin E C Meyers, Neal Sondheimer

Abstract readCase Reports
In one paragraph

Article in Pediatric nephrology (Berlin, Germany), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Tissue-specific mitochondrial DNA,Molecular genetics and metabolism reports · 2025
    Article
  3. Article
  4. Article
  5. Mitochondrial DNA mutations in renal disease: an overview.Pediatric nephrology (Berlin, Germany) · 2021
    Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Hepatocyte Nuclear Factor-1Journal of the American Society of Nephrology : JASN · 2017
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Renal manifestations of genetic mitochondrial disease.International journal of nephrology and renovascular disease · 2014
    Review
  19. Article
  20. Mitochondrial disease--an important cause of end-stage renal failure.Pediatric nephrology (Berlin, Germany) · 2013
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Kristin E D'AcoDivision of Genetics, Department of Pediatrics, University of Rochester School of Medicine and Dentistry, 601 Elmwood Ave, Box 777, Rochester, NY 14623, USA.
Megan Manno
Colleen Clarke
Jaya Ganesh
Kevin E C Meyers
Neal Sondheimer
Children's Hospital of Philadelphia · USUniversity of Pennsylvania · USUniversity of Rochester · US

Funding

Mitochondrial Transcription and Pediatric DiseaseK08HD058022 · NICHD · CHILDREN'S HOSP OF PHILADELPHIA · PI SONDHEIMER, NEAL J · 2009 to 2013
$670k
NICHD NIH HHS HD58022NICHD NIH HHS K08 HD058022
6 · The paper itself

Abstract

backgroundWe identified a mitochondrial tRNA mutation (m.586 G > A) in a patient with renal failure and symptoms consistent with a mitochondrial cytopathy. This mutation was of unclear significance due to the absence of consistent reports of linkage to specific disease phenotypes and any data pertaining to its effects on mitochondrial function. CASE-DIAGNOSIS/TREATMENT: A 16-month-old girl with failure-to-thrive, developmental regression, persistent lactic acidosis, hypotonia, gastrointestinal dysmotility, adrenal insufficiency, and hematologic abnormalities developed hypertension and renal impairment with chronic tubulointerstitial fibrosis, progressing to renal failure with the need for peritoneal dialysis. Evaluation of her muscle and blood led to the identification of a mutation of the mitochondrial tRNA for phenylalanine, m.586 G > A.

conclusionsThe m.586 G > A mutation is pathogenic and a cause of end-stage renal disease in childhood. The mutation interferes with the stability of tRNA(Phe) and affects the translation of mitochondrial proteins and the stability of the electron transport chain.

Indexed as

MutationCells, CulturedDNA Mutational AnalysisFatal OutcomeFemaleFibrosisGenetic Predisposition to DiseaseHumansInfantKidneyKidney Failure, ChronicMitochondrial DiseasesMitochondrial ProteinsOxygen ConsumptionPeritoneal DialysisPhenotypeMitochondrial ProteinsRNARNA, MitochondrialRNA, Transfer, Phe

Identifiers

PMID23135609
PMCPMC3557766
OpenAlexW1986714995

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.